Facing Ethical Dilemmas: Scientists Must Lead The Charge

Recent revelations of scientific misconduct and fraud have brought into question the claim of the science community to self-regulation. Treatises on research fraud and problems in "peer review" proliferate, and even the United States Secret Service reportedly has been enlisted in the search for fraud in scientific notebooks (Science, 251:1168-72, 1991). The old assumption that fraud inevitably will be revealed seems unacceptable. The stakes have become too high to rely on traditional mechanism

Written byTom Hoshiko
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The old assumption that fraud inevitably will be revealed seems unacceptable. The stakes have become too high to rely on traditional mechanisms. Incidents of misconduct have alarmed not only the science community and its onlookers, but more significantly, the U.S. Congress, where some factions feel regulation is necessary.

In 1988, the Institute of Medicine convened a workshop that produced 16 recommendations, some of which have been implemented by federal regulatory action, including establishment of the Office of Scientific Integrity and the Office of Scientific Integrity Review ("The Responsible Conduct of Research in the Health Sciences," National Academy Press, 1989; The FASEB Journal, 5:2512, 1991). In addition to the establishment of these offices, adoption of policies and procedures to promote responsible conduct of research is now required of grantee institutions as well as internally by the National Institutes of Health. There is the fear in the science community that more restrictions, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies